Nu-V3 is a patented and trademark registered neuro-modulation device to treat pain, anxiety, depression and sleep-lessness, which is miniature, wearable, non-invasive and non-pharmaceutical.
Nu-Life Solutions is the global developer of the Nu-V3 technology and delivers Nu-V3 through regional providers such as Nu-Life USA, Nu-Life Europe, Nu-Life Japan, Nu-Life Latin America and Nu-Life Canada.
Neuromodulation by Nu-V3
Neuromodulation is technology that acts directly upon nerves. It is the alteration - or modulation - of nerve activity by delivering either electrical or pharmaceutical (drug) agents directly to a target area.
Nu-Life's Nu-V3 technology delivers a micro-electrical signal to create the cranial nerve stimulation non-invasively and non-pharmaceutically directly through the auricular (ear) area, all while allowing the patient to perform almost any everyday activity.
More on neuromodulation,
Information contained on this website is intended to educate the viewer about Nu-V3, the Nu-V3 Program, corporate status and plan for market entry 2021. Use of Nu-V3 and Nu-V3 treatment programs are conducted under strict FDA guidelines and are IRB approved. Some areas on this website are confidential and password protected, containing proprietary information and intellectual property of Nu-Life Solutions and Nu-Life Products, Inc, which may not be reproduced or disclosed under any circumstances without the express written permission of Nu-Life Solutions, SEZC.